- Report
- September 2019
- 187 Pages
Global
From €4703EUR$4,950USD£4,032GBP
- Report
- June 2021
- 43 Pages
Global
- Report
- September 2020
- 147 Pages
Asia Pacific
From €1995EUR$2,100USD£1,711GBP
€2850EUR$3,000USD£2,444GBP
- Report
- April 2020
- 177 Pages
Global
From €3026EUR$3,185USD£2,595GBP
€4323EUR$4,550USD£3,707GBP
- Report
- April 2023
- 100 Pages
United Kingdom
From €4513EUR$4,750USD£3,870GBP
- Report
- August 2022
- 110 Pages
Global
From €4513EUR$4,750USD£3,870GBP
- Report
- January 2021
- 120 Pages
Global
From €4513EUR$4,750USD£3,870GBP
- Report
- June 2020
- 86 Pages
Europe
From €4513EUR$4,750USD£3,870GBP
- Report
- May 2020
- 71 Pages
North America
From €4513EUR$4,750USD£3,870GBP
- Report
- April 2024
- 185 Pages
From €4655EUR$4,900USD£3,992GBP
- Report
- April 2024
- 185 Pages
From €4655EUR$4,900USD£3,992GBP
- Report
- February 2018
- 15 Pages
Global
- Report
- August 2022
- 122 Pages
Middle East, Africa
From €1995EUR$2,100USD£1,711GBP
€2850EUR$3,000USD£2,444GBP
- Report
- August 2022
- 131 Pages
Asia Pacific
From €1995EUR$2,100USD£1,711GBP
€2850EUR$3,000USD£2,444GBP
- Report
- March 2022
- 120 Pages
Global
From €2375EUR$2,500USD£2,037GBP
- Report
- May 2023
- 255 Pages
Global
From €4555EUR$4,795USD£3,906GBP
- Report
- May 2023
- 80 Pages
Saudi Arabia
From €2465EUR$2,595USD£2,114GBP
- Report
- May 2023
- 80 Pages
India
From €2465EUR$2,595USD£2,114GBP
- Report
- April 2019
- 120 Pages
Global
From €2423EUR$2,550USD£2,077GBP
€2850EUR$3,000USD£2,444GBP
- Report
- October 2023
- 98 Pages
Global
From €3500EUR$3,946USD£3,106GBP
Targeted Drug Delivery System (TDDS) is a specialized area within the broader pharmacological field of Drug Delivery. TDDS aims to direct medication to specific cells, tissues, or organs, thereby increasing the concentration of the drug at the intended site of action while minimizing its presence in the rest of the body. This method potentially reduces side effects and enhances treatment efficacy. The market for these systems encompasses a wide range of technologies and platforms, such as nanoparticles, liposomes, and biodegradable polymers designed to release pharmaceutical compounds in a controlled manner. The field has been propelled by advances in biotechnology, nanotechnology, and molecular biology, which have contributed to the development of novel targeted drug delivery mechanisms. These include antibodies, receptor-mediated delivery systems, and gene-delivery vectors. TDDS is used in addressing various medical conditions, with cancer therapy being a particularly active area due to the need for precise drug delivery to tumor cells.
Several companies specialize in the research and development of Targeted Drug Delivery Systems, contributing to the maturation of this market. Some notable players in the field include Alkermes, BIND Therapeutics, DEPArray Technology, Genentech, Immunomedics, Inc., and Kite Pharma. These companies have a diverse product portfolio of targeted delivery technologies and are engaged in the development of innovative treatments for a wide range of diseases, striving to improve therapeutic outcomes and patient quality of life. Show Less Read more